Click Here to Register | Login

Optimizing outcomes for patients with non-metastatic pancreatic cancer

Date: December 7, 2022

Time: 04:30PM - 06:00PM

You must be registered to participate!

Mark J. Truty, M.D., M.S., and colleagues discuss new research improving outcomes in pancreatic cancer. The team shares updates on staging exams, optimal response assessment and novel surgical procedures for traditionally inoperable patients.

Goals:

  1. What initial staging exams are available and why and when they should be used
  2. Determining if your patient has had an optimal response to neoadjuvant therapy
  3. Understanding which patients are eligible for curative intent surgery

Topics for discussion:

  1. State of the art staging exams - radiologic, biochemical, and procedural
  2. Chemotherapeutic options and optimal response assessment
  3. Novel surgical procedures for traditionally inoperable patients
Moderators: Speakers:


Click Here to Register | Login